Suddenly, cannabis-related, hemp-derived CBD is almost everywhere. CBD’s FDA status is murky, and we know very little about its benefits, thanks in part to its former place on DEA Schedule 1. How much has been proven about its supposed health qualities? What are the risks? Experts discuss in depth.
Some FDA commissioner candidates have proposed radical reform. Experts discuss what reform might look like and what the FDA needs to better succeed.